4.8 Article

Enhancer-promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustness

Journal

NATURE GENETICS
Volume 55, Issue 2, Pages 280-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41588-022-01295-6

Keywords

-

Ask authors/readers for more resources

The mechanism of how enhancers activate their target promoters is not fully understood. Through genetic manipulation of the Sox2 locus in mice, it is found that CTCF-mediated loops are not necessary for the interaction and expression of the Sox2 gene with distal enhancers. Insertion of CTCF motifs between Sox2 and its distal enhancers creates boundaries that affect transcriptional output, but enhancer contacts and induction of gene expression are still observed. Strong boundaries completely abolish Sox2 expression in the anterior foregut, suggesting the importance of regulatory activity density in maintaining faithful gene expression and phenotypic robustness.
How enhancers activate their distal target promoters remains incompletely understood. Here we dissect how CTCF-mediated loops facilitate and restrict such regulatory interactions. Using an allelic series of mouse mutants, we show that CTCF is neither required for the interaction of the Sox2 gene with distal enhancers, nor for its expression. Insertion of various combinations of CTCF motifs, between Sox2 and its distal enhancers, generated boundaries with varying degrees of insulation that directly correlated with reduced transcriptional output. However, in both epiblast and neural tissues, enhancer contacts and transcriptional induction could not be fully abolished, and insertions failed to disrupt implantation and neurogenesis. In contrast, Sox2 expression was undetectable in the anterior foregut of mutants carrying the strongest boundaries, and these animals fully phenocopied loss of SOX2 in this tissue. We propose that enhancer clusters with a high density of regulatory activity can better overcome physical barriers to maintain faithful gene expression and phenotypic robustness. Genetic manipulation of the Sox2 locus in mice shows that gene activation by distal enhancers does not require CTCF-mediated loops and can occur across ectopic CTCF-mediated boundaries. The ability to bypass CTCF boundaries varies with their insulation strength and the tissue-specific enhancers responsible for activation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Cavβ1 regulates T cell expansion and apoptosis independently of voltage-gated Ca2+ channel function

Serap Erdogmus, Axel R. Concepcion, Megumi Yamashita, Ikjot Sidhu, Anthony Y. Tao, Wenyi Li, Pedro P. Rocha, Bonnie Huang, Ralph Garippa, Boram Lee, Amy Lee, Johannes W. Hell, Richard S. Lewis, Murali Prakriya, Stefan Feske

Summary: The regulatory beta subunit of voltage-gated calcium channels regulates T cell function despite no evidence that these channels were functional within T cells during activation.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Transcriptional regulation and chromatin architecture maintenance are decoupled functions at the Sox2 locus

Tiegh Taylor, Natalia Sikorska, Virlana M. Shchuka, Sanjay Chahar, Chenfan Ji, Neil N. Macpherson, Sakthi D. Moorthy, Marit A. C. de Kort, Shanelle Mullany, Nawrah Khader, Zoe E. Gillespie, Lida Langroudi, Ian C. Tobias, Tineke L. Lenstra, Jennifer A. Mitchell, Tom Sexton

Summary: The connection between transcriptional control and chromatin architecture is not clearly understood. This study using genome editing and chromatin interaction analysis in mouse embryonic stem cells found a disconnect where Sox2 transcriptional activation is traced back to a few key transcription factor binding sites that have no effect on promoter-enhancer interaction frequencies or topological domain organization. Maintenance of local chromatin architecture, including at the topologically associating domain boundary downstream from the Sox2 enhancer, is distributed across multiple transcription factor-bound regions and is independent of CTCF. Additionally, disruption of promoter-enhancer interactions has no effect on Sox2 transcription. These findings suggest that many transcription factors can modulate chromatin architecture independently of CTCF.

GENES & DEVELOPMENT (2022)

Article Multidisciplinary Sciences

Chromatin structure undergoes global and local reorganization during murine dendritic cell development and activation

Daisuke Kurotaki, Kenta Kikuchi, Kairong Cui, Wataru Kawase, Keita Saeki, Junpei Fukumoto, Akira Nishiyama, Kisaburo Nagamune, Keji Zhao, Keiko Ozato, Pedro P. Rocha, Tomohiko Tamura

Summary: This study comprehensively determined higher-order chromatin structures by Hi-C in DC progenitors and cDC subpopulations. The results showed that chromatin activation was initially induced at the MDP stage during cDC differentiation, followed by a shift from inactive to active nuclear compartments in CDPs. This study also identified the transcription factor IRF8 as a mediator of chromatin activation and changes in the active compartments in DC progenitors. Furthermore, the study found preestablished chromatin structures of host defense-related gene loci in unstimulated cDCs, which may contribute to the rapid responses to pathogens.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

Extensive co-binding and rapid redistribution of NANOG and GATA6 during emergence of divergent lineages

Joyce J. Thompson, Daniel J. Lee, Apratim Mitra, Sarah Frail, Ryan K. Dale, Pedro P. Rocha

Summary: The authors demonstrate that the transcription factors NANOG and GATA6 co-bind the same enhancers in common progenitors before the emergence of divergent epiblast and primitive endoderm lineages. This co-binding may play a role in maintaining plasticity and facilitating lineage differentiation. They propose that the co-binding of GATA6 and NANOG at shared enhancers helps maintain the pluripotent state of cells and promotes the establishment of lineage-specific transcriptional programs in epiblast and primitive endoderm.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

An epigenome atlas of neural progenitors within the embryonic mouse forebrain

Christopher T. Rhodes, Joyce J. Thompson, Apratim Mitra, Dhanya Asokumar, Dongjin R. Lee, Daniel J. Lee, Yajun Zhang, Eva Jason, Ryan K. Dale, Pedro P. Rocha, Timothy J. Petros

Summary: The authors utilized a multimodal approach to characterize the transcriptomic and epigenetic landscape of distinct regions in the embryonic mouse forebrain, uncovering diverse chromatin landscapes and regulatory mechanisms. This study is of great significance in enhancing our understanding of neurodevelopment and mechanisms of neurological diseases.

NATURE COMMUNICATIONS (2022)

Article Genetics & Heredity

MLL3/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner

Guojia Xie, Ji-Eun Lee, Anna D. Senft, Young-Kwon Park, Younghoon Jang, Shreeta Chakraborty, Joyce J. J. Thompson, Kaitlin McKernan, Chengyu Liu, Todd S. S. Macfarlan, Pedro P. P. Rocha, Weiqun Peng, Kai Ge

Summary: The enzymatic activities of MLL3 and MLL4 are critical for embryonic development and embryonic stem cell differentiation.

NATURE GENETICS (2023)

Article Oncology

Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency

Olga Kim, Madison Butler, Zach Sergi, Robert W. Robey, Meili Zhang, Raj Chari, Ying Pang, Guangyang Yu, Wei Zhang, Hua Song, Dionne Davis, Robert G. Hawley, Xinyu Wen, Herui Wang, Martha Quezado, Bao Tran, Mythili Merchant, Alice Ranjan, Frank B. Furnari, Javed Khan, Mark R. Gilbert, Christopher Ryan Miller, Michael M. Gottesman, Yves Pommier, Jing Wu

Summary: The study found that GBM cells lacking PTEN expression are more sensitive to LMP400, but restoring PTEN expression reduces sensitivity to the treatment. Combining LMP400 with Niraparib induces G2/M arrest, DNA damage, suppression of homologous recombination-related proteins, and activates caspase 3/7 activity more significantly in PTEN-null cells compared to PTEN-WT cells. Animal studies confirmed the anti-glioma effect of the drug combination and sufficient BBB penetration.

NEURO-ONCOLOGY ADVANCES (2023)

Article Oncology

A Therapeutically Targetable NOTCH1-SIRT1- KAT7 Axis in T-cell Leukemia

Olga Lancho, Amartya Singh, Victoria da Silva-Diz, Maya Aleksandrova, Jesminara Khatun, Luca Tottone, Patricia Renck Nunes, Shirley Luo, Caifeng Zhao, Haiyan Zheng, Eric Chiles, Zhenyu Zuo, Pedro P. Rocha, Xiaoyan Su, Hossein Khibaanban, Danie Herran

Summary: We identified a therapeutic vulnerability in T-ALL, where NOTCH1 activates SIRT1 through an enhancer region, and SIRT1 deacetylates and activates KAT7. Targeting SIRT1 shows significant anti-leukemic effects, partly mediated by KAT7 inactivation. This study reveals therapeutic targets in T-ALL and uncovers a regulatory mechanism between deacetylase/acetyltransferase activities.

BLOOD CANCER DISCOVERY (2023)

Article Biochemistry & Molecular Biology

AGO2 silences mobile transposons in the nucleus of quiescent cells

Laura Sala, Manish Kumar, Mahendra Prajapat, Srividya Chandrasekhar, Rachel L. Cosby, Gaspare La Rocca, Todd S. Macfarlan, Parirokh Awasthi, Raj Chari, Michael Kruhlak, Joana A. Vidigal

Summary: AGO2 accumulates in the nucleus of quiescent cells and represses the expression of young retrotransposons by binding to them co-transcriptionally. This study reveals the nuclear function of AGO2 and its role as a genome-defense system in quiescence.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2023)

Article Oncology

Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Yoshimi Endo Greer, Lidia Hernandez, Emily M. J. Fennell, Manjari Kundu, Donna Voeller, Raj Chari, Samuel F. Gilbert, Thomas S. K. Gilbert, Shashikala Ratnayake, Binwu Tang, Markus Hafner, Qingrong Chen, Daoud Meerzaman, Edwin Iwanowicz, Christina M. Annunziata, Lee M. Graves, Stanley Lipkowitz

Summary: ClpP agonists inhibit breast cancer cell proliferation and CSC function by modulating multiple metabolic pathways essential to CSC function.

CANCER RESEARCH COMMUNICATIONS (2022)

No Data Available